✦ LIBER ✦

Esophagectomy for metastatic carcinoma of the esophagus from lung cancer

✍ Scribed by Tadayuki Oka; Hiroyoshi Ayabe; Katsunobu Kawahara; Yutaka Tagawa; Shinsuke Hara; Hiroharu Tsuji; Hiroyuki Kusano; Masao Tomita; Masamoto Nakano

Publisher: John Wiley and Sons
Year: 1993
Tongue: English
Weight: 486 KB
Volume: 71
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19930515)71:10<2958::aid-cncr2820711012>3.0.co;2-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Prognostic factors after extended esopha

Prognostic factors after extended esophagectomy for squamous cell carcinoma of the thoracic esophagus

✍ Tachibana, Mitsuo; Kinugasa, Shoichi; Dhar, Dipok Kumar; Kotoh, Tsukasa; Shibaki 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 85 KB 👁 1 views

## Backgrounds and Objectives: In Japan, extended esophagectomy with extensive lymphadenectomy has become the standard surgical procedure for carcinoma of the thoracic esophagus. Although mortality and morbidity rates after such extensive esophagectomy have been acceptable, the long-term outcomes

Lymph node and perinodal tissue tumor in

Lymph node and perinodal tissue tumor involvement in patients with esophagectomy and three-field lymphadenectomy for carcinoma of the esophagus

✍ Baba, Masamichi; Aikou, Takashi; Natsugoe, Shoji; Kusano, Chikara; Shimada, Mari 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 274 KB

## Background: Lymph node metastasis is a definitive prognostic factor; however, perinodal fat tumor invasion has not been fully elucidated. ## Methods: Periesophageal nodes and the surrounding fibrofatty tissue obtained from 131 patients who underwent esophagectomy were examined. ## Results: O

Split-course accelerated radiation thera

Split-course accelerated radiation therapy combined with carboplatin and 5-fluorouracil for palliation of metastatic or unresectable carcinoma of the esophagus

✍ Susan G. Urba; Andrew T. Turrisi III 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 464 KB 👁 1 views

Combination chemotherapy with adriamycin

Combination chemotherapy with adriamycin, etoposide, and cyclophosphamide for small cell carcinoma of the lung. A study by the EORTC lung cancer working party (Belgium)

✍ J. Klastersky; J. P. Sculier; J. P. Dumont; D. Becquart; G. Vandermoten; P. Rocm 📂 Article 📅 1985 🏛 John Wiley and Sons 🌐 English ⚖ 425 KB 👁 1 views

Phase II clinical trial with 5-fluoroura

Phase II clinical trial with 5-fluorouracil, recombinant interferon-α-2b, and cisplatin for patients with metastatic or regionally advanced carcinoma of the esophagus

✍ Scott Wadler; Hilda Haynes; Jonathan J. Beitler; Xiaoping Hu; Stanley Fell; Marg 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 393 KB 👁 1 views

## Background: Recombinant interferon-alpha (ifn) augments the cytotoxicity of both 5-fluorouracil (5-fu) and cisplatin in vitro. a phase ii study of 5-fu and ifn resulted in response rates of 25-27% in patients with metastatic esophageal carcinoma. ## Methods: A phase ii trial was initiated to d

Paclitaxel and carboplatin adjuvant ther

Paclitaxel and carboplatin adjuvant therapy alone or with radiotherapy for resected nonsmall cell lung carcinoma : A feasibility study of the Minnie Pearl Cancer Research Network

✍ F. Anthony Greco; Howard A. Burris III; James R. Gray; Eric L. Raefsky; Charles 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB 👁 1 views